MiMedx Group Quarterly Balance Sheet
NASDAQ: MDXGHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MiMedx Group financial position
As of Jun 30, 2026, MiMedx Group reported total assets of $281.0 million, down 3.5% from a year earlier against total liabilities of $65.0 million. Shareholders' equity stood at $216.0 million, or 76.9% of assets. The company held $135.8 million in cash and equivalents against $17.2 million of debt, a net cash position of $118.6 million.
The current ratio (current assets divided by current liabilities) was 5.33, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.08.
Summary generated from market data by MetaCap's automated system. Methodology
MiMedx Group balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 135.84M | 159.77M | 166.12M | 142.08M | 118.87M | 106.43M | 104.42M | 88.80M | 69.04M | 48.49M | 82.00M | 81.16M |
| Receivables | 41.30M | 46.03M | 75.71M | 78.19M | 69.23M | 62.29M | 55.83M | 54.03M | 52.80M | 57.02M | 53.87M | 49.01M |
| Inventory | 20.93M | 26.23M | 25.34M | 26.50M | 24.89M | 24.07M | 23.81M | 24.25M | 25.06M | 24.45M | 21.02M | 19.07M |
| Total Current Assets | 205.37M | 240.33M | 277.47M | 254.09M | 220.88M | 200.11M | 191.89M | 172.14M | 154.02M | 138.85M | 164.26M | 154.50M |
| Property, Plant & Equipment | 4.91M | 4.76M | 4.71M | 5.00M | 5.39M | 5.77M | 5.94M | 6.45M | 6.82M | 7.34M | 6.97M | 7.09M |
| Goodwill | 19.44M | 19.44M | 19.44M | 19.44M | 19.44M | 19.44M | 19.44M | 19.44M | 19.44M | 19.44M | 19.44M | 19.44M |
| Intangible Assets | 12.09M | 13.14M | 14.16M | 11.15M | 12.03M | 11.06M | 11.63M | 11.20M | 12.05M | 12.55M | 5.26M | 5.39M |
| Total Assets | 281.00M | 308.68M | 342.65M | 318.99M | 291.11M | 270.42M | 263.92M | 243.89M | 230.18M | 221.68M | 239.05M | 189.02M |
| Accounts Payable | 8.29M | 11.46M | 14.53M | 11.41M | 8.50M | 8.87M | 7.41M | 6.92M | 7.60M | 9.70M | 9.05M | 9.17M |
| Short-Term Debt | 1.50M | 1.50M | 1.50M | 1.38M | 1.25M | 1.13M | 1.00M | 1.00M | 1.00M | 1.00M | 1.00M | — |
| Total Current Liabilities | 38.50M | 44.55M | 64.27M | 57.68M | 50.29M | 42.62M | 45.59M | 41.94M | 40.01M | 42.22M | 46.01M | 43.63M |
| Long-Term Debt | 15.71M | 16.09M | 16.47M | 16.84M | 17.21M | 17.53M | 17.83M | 18.02M | 18.25M | 18.45M | 48.10M | 48.97M |
| Total Liabilities | 65.00M | 65.74M | 86.11M | 80.04M | 74.48M | 67.64M | 70.81M | 62.88M | 62.14M | 65.95M | 96.33M | 95.20M |
| Shareholders' Equity | 216.00M | 242.94M | 256.55M | 238.95M | 216.62M | 202.78M | 193.11M | 181.01M | 168.04M | 155.73M | 142.72M | 1.33M |
| Retained Earnings | -68.38M | -53.54M | -42.68M | -57.87M | -74.62M | -84.24M | -91.26M | -98.70M | -106.79M | -124.42M | -133.68M | -187.16M |
| Total Debt | 17.21M | 17.59M | 17.97M | 18.21M | 18.46M | 18.66M | 18.83M | 19.02M | 19.25M | 19.45M | 49.10M | 48.97M |
| Net Cash (Debt) | 118.63M | 142.18M | 148.15M | 123.87M | 100.41M | 87.77M | 85.59M | 69.78M | 49.79M | 29.03M | 32.90M | 32.20M |
| Shares Outstanding | 145.72M | 148.93M | 148.09M | 148.08M | 147.92M | 147.61M | 146.93M | 146.96M | 146.75M | 147.53M | 146.23M | 116.36M |
This table shows 12 quarterly periods of MiMedx Group's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow MDXG's reporting calendar. What is a balance sheet?